Collectively, our results showed that these biogenic SeNPs has the ability to inhibit the growth of prostate cancer cell through the activation of TNF and IRF1 and the suppression of AR. Here, we hypothesize that probably these two events are either interconnected (31, 32) with an unexplored pathway or they are acting differently to induce necroptosis. Here, IRF1 is linked to prostate cancer.